
CRSP
Healthcare · Biotechnology · $4.10B market cap
$42.24-0.38 (-0.9%)Nov 13, 4:21 PM EST
Latest report
After the close
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Dec 31, 2026
EPS trend, 90 days to now · -1.5% over 90 days · 30-day revisions 7 up, 7 down
Beat estimates in 1 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Nov 2, 2026 | After the close | -1.06 | -1.15 | -8.5% |
| Aug 3, 2026 | After the close | -1.10 | -0.94 | +14.5% |
| May 4, 2026 | After the close | -1.23 | -1.28 | -4.1% |
| Feb 12, 2026 | After the close | -1.23 | -1.37 | -11.4% |
| Nov 10, 2025 | Before the open | -1.29 | -1.17 | +9.3% |
| Aug 4, 2025 | After the close | -1.40 | -1.29 | +7.9% |
| May 6, 2025 | After the close | -1.28 | -1.58 | -23.4% |
| Feb 11, 2025 | After the close | -1.19 | -0.44 | +62.9% |
| Nov 5, 2024 | Before the open | -1.40 | -1.01 | +27.9% |
| Aug 5, 2024 | After the close | -1.43 | -1.49 | -4.2% |
| May 8, 2024 | After the close | -1.33 | -1.43 | -7.5% |
| Feb 21, 2024 | Before the open | 0.05 | 1.10 | +2100.0% |
| Nov 6, 2023 | After the close | -1.95 | -1.41 |
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious human diseases using its Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. The company's CRISPR/Cas9 is a technology for gene editing which is the process of precisely altering specific sequences of genomic DNA. It has a portfolio of therapeutic…
| +27.7% |
| Aug 7, 2023 | After the close | -2.10 | -0.98 | +53.3% |
| May 8, 2023 | After the close | -1.64 | -0.67 | +59.1% |
| Feb 21, 2023 | After the close | -2.30 | -1.41 | +38.7% |
| Nov 1, 2022 | After the close | -2.24 | -2.24 | 0.0% |
| Aug 8, 2022 | Before the open | -2.21 | -2.40 | -8.6% |
| May 9, 2022 | After the close | -1.97 | -2.32 | -17.8% |
| Feb 15, 2022 | After the close | -1.78 | -1.84 | -3.4% |
| Nov 3, 2021 | After the close | -1.76 | -1.67 | +5.1% |
| Jul 29, 2021 | After the close | 3.12 | 9.44 | +202.6% |
| Apr 27, 2021 | After the close | -1.47 | -1.51 | -2.7% |
| Feb 16, 2021 | After the close | -1.27 | -1.50 | -18.1% |
| Oct 28, 2020 | Before the open | -1.19 | -1.32 | -10.9% |
| Jul 27, 2020 | After the close | -0.99 | -1.30 | -31.3% |
| Apr 28, 2020 | After the close | -1.04 | -1.15 | -10.6% |
| Feb 12, 2020 | After the close | -0.63 | 0.51 | +181.0% |
| Oct 28, 2019 | Before the open | 1.79 | 2.40 | +34.1% |
| Jul 29, 2019 | After the close | -0.90 | -1.01 | -12.2% |
| Apr 29, 2019 | After the close | -0.90 | -0.93 | -3.3% |
| Feb 25, 2019 | Before the open | -0.78 | -0.92 | -17.9% |
| Nov 7, 2018 | After the close | -0.74 | -1.07 | -44.6% |
| Aug 7, 2018 | After the close | -0.64 | -0.82 | -28.1% |
| May 8, 2018 | Before the open | -0.67 | -0.62 | +7.5% |
| Mar 8, 2018 | After the close | -0.67 | 0.00 | +100.5% |